Insights

Innovative Diagnostic Technology BioAI Health is leveraging advanced multimodal AI and deep neural network pipelines to detect genetic alterations and develop predictive biomarkers for early cancer diagnosis, presenting opportunities for collaborations in diagnostics and personalized medicine solutions.

Strategic Industry Partnerships Recent partnerships with biopharmaceutical companies like Arbele highlight BioAI's interest in expanding its reach within immunotherapy and cancer treatment sectors, offering potential avenues for joint development, clinical trials, and co-marketing initiatives.

Experienced Leadership Team With a seasoned team having over 30 years of expertise in digital pathology and AI, BioAI is positioned to accelerate product development and customer adoption, seeking collaborations that benefit from deep industry knowledge and innovative AI applications.

Market Focus on Oncology BioAI's concentration on lung cancer and other oncology targets aligns with market trends favoring precision medicine, indicating sales opportunities with healthcare providers, research institutions, and pharmaceutical companies investing in cancer diagnostics and targeted therapies.

Growth and Funding Potential With a current revenue between one and ten million dollars and ongoing funding efforts, BioAI is in an expansion phase, making it receptive to strategic investors, technology partners, and enterprise customers interested in cutting-edge AI-driven cancer diagnostics.

Similar companies to BioAI Health

BioAI Health Tech Stack

BioAI Health uses 8 technology products and services including Hotjar, oEmbed, Font Awesome, and more. Explore BioAI Health's tech stack below.

  • Hotjar
    Analytics
  • oEmbed
    Dev Tools
  • Font Awesome
    Font Scripts
  • imagesLoaded
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • PyTorch
    Machine Learning
  • Elementor
    Page Builders
  • Hostinger
    Web Hosting

Media & News

BioAI Health's Email Address Formats

BioAI Health uses at least 1 format(s):
BioAI Health Email FormatsExamplePercentage
FLast@bioaihealth.comJDoe@bioaihealth.com
100%

Frequently Asked Questions

Where is BioAI Health's headquarters located?

Minus sign iconPlus sign icon
BioAI Health's main headquarters is located at 1662 Elm Street Manchester, New Hampshire 03101 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is BioAI Health's official website and social media links?

Minus sign iconPlus sign icon
BioAI Health's official website is bioaihealth.com and has social profiles on LinkedInCrunchbase.

What is BioAI Health's SIC code NAICS code?

Minus sign iconPlus sign icon
BioAI Health's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioAI Health have currently?

Minus sign iconPlus sign icon
As of April 2026, BioAI Health has approximately 15 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Ceo, President & Co-Founder: T. C.Chief Innovation Officer & Co-Founder: A. J.Medical Director: M. B.. Explore BioAI Health's employee directory with LeadIQ.

What industry does BioAI Health belong to?

Minus sign iconPlus sign icon
BioAI Health operates in the Biotechnology Research industry.

What technology does BioAI Health use?

Minus sign iconPlus sign icon
BioAI Health's tech stack includes HotjaroEmbedFont AwesomeimagesLoadedSwiperPyTorchElementorHostinger.

What is BioAI Health's email format?

Minus sign iconPlus sign icon
BioAI Health's email format typically follows the pattern of FLast@bioaihealth.com. Find more BioAI Health email formats with LeadIQ.

How much funding has BioAI Health raised to date?

Minus sign iconPlus sign icon
As of April 2026, BioAI Health has raised $500K in funding. The last funding round occurred on Apr 09, 2024 for $500K.

When was BioAI Health founded?

Minus sign iconPlus sign icon
BioAI Health was founded in 2020.

BioAI Health

Biotechnology ResearchNew Hampshire, United States11-50 Employees

At BioAI, our mission is to deliver cancer tests that improve patient outcomes and save lives. 

Our vision starts with lung cancer. AI-powered predictive tests can reduce the time and expense required to identify the best therapy for patients.

We are a seasoned team of digital pathology/AI industry experts with 30+ years of experience from development through commercialization, so we know which questions to ask, how to build solutions, and how to implement them. 

Our approach is unique, leveraging multimodal data, pathology, genomics, and real-world evidence alongside the latest AI/ML technologies. We focus on causal biology to understand morphology, enabling us to deliver the highest-quality predictive biomarkers for clinical development and/or patient identification in early diagnostic testing.

Section iconCompany Overview

Headquarters
1662 Elm Street Manchester, New Hampshire 03101 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $500K

    BioAI Health has raised a total of $500K of funding over 2 rounds. Their latest funding round was raised on Apr 09, 2024 in the amount of $500K.

  • $1M$10M

    BioAI Health's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $500K

    BioAI Health has raised a total of $500K of funding over 2 rounds. Their latest funding round was raised on Apr 09, 2024 in the amount of $500K.

  • $1M$10M

    BioAI Health's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.